Based on this latest update could estimate full year NPAT of around $42 million. Based on market cap of around $650 million after today's 7% jump gives a PE of around 15. Not exceptionally high for a company achieving 30% NPAT growth over previous year. Dividends should also increase. This is in a great sector (health, beauty, pharmaceuticals), I would expect there is room for this stock to go quite a bit higher yet.
Based on this latest update could estimate full year NPAT of...
-
- There are more pages in this discussion • 1 more message in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
